A 40-year-old Human Resources Manager, Bisi, with uterine fibroids, delayed her treatment for over  four years for fear of ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...

Although hysterectomy remains the most common procedure for treating fibroids and fibroids are the leading indication for ...

Uterine fibroids are the major reason for the removal of the uterus by hysterectomy. However, researchers recommend minimally ...

The following is a summary of “Currently Available Treatment Modalities for Uterine Fibroids,” published in the May 2024 issue of Obstetrics & Gynecology by Micić et al. Uterine fibroids are common ...

ASHG 2024 professional awardees include two awardees in the lifetime achievement category and one awardee each in the ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...